Fibrosis News and Research

RSS
Fibrosis is the growth of fibrous tissue.
Researchers identify genetic risk factors contributing to pneumonia susceptibility and severity

Researchers identify genetic risk factors contributing to pneumonia susceptibility and severity

Owlstone Medical introduces breath biopsy panel for respiratory diseases

Owlstone Medical introduces breath biopsy panel for respiratory diseases

Scientists make new discovery in the quest for novel antibiotics

Scientists make new discovery in the quest for novel antibiotics

New taxonomic classification of non-skeletal rare congenital disorders with impact on bone physiology

New taxonomic classification of non-skeletal rare congenital disorders with impact on bone physiology

Study finds association between severity of COVID-19 and shorter telomeres

Study finds association between severity of COVID-19 and shorter telomeres

Study: Initial COVID-19 severity is not linked to later poor respiratory problems

Study: Initial COVID-19 severity is not linked to later poor respiratory problems

Chemicals in e-cigarettes disrupt the gut barrier and trigger inflammation

Chemicals in e-cigarettes disrupt the gut barrier and trigger inflammation

Potential role of chitinase 3-like-1 in severity of COVID-19

Potential role of chitinase 3-like-1 in severity of COVID-19

Novel low molecular weight dextran-sulphate could play a key role in glaucoma treatment

Novel low molecular weight dextran-sulphate could play a key role in glaucoma treatment

ACE2 receptor is responsible for the wide host range of SARS-CoV-2

ACE2 receptor is responsible for the wide host range of SARS-CoV-2

RedHill Biopharma: RHB-204 receives FDA Fast Track designation for treatment of NTM disease

RedHill Biopharma: RHB-204 receives FDA Fast Track designation for treatment of NTM disease

High altitude experts explain pneumolysis caused by COVID-19

High altitude experts explain pneumolysis caused by COVID-19

CN Bio and University of Melbourne announce partnership focused on respiratory therapies for recovering COVID-19 patients

CN Bio and University of Melbourne announce partnership focused on respiratory therapies for recovering COVID-19 patients

Research examines processes of lung scarring and chronic rejection of organ after transplantation

Research examines processes of lung scarring and chronic rejection of organ after transplantation

Antifungal drug improves key biomarkers in the noses of patients with cystic fibrosis

Antifungal drug improves key biomarkers in the noses of patients with cystic fibrosis

A protein may be responsible for triggering lung scarring in scleroderma patients

A protein may be responsible for triggering lung scarring in scleroderma patients

BU researchers awarded $2.4 million NIH grant to study idiopathic pulmonary fibrosis

BU researchers awarded $2.4 million NIH grant to study idiopathic pulmonary fibrosis

Regulating a protein channel responsible for transporting chloride across cell membranes

Regulating a protein channel responsible for transporting chloride across cell membranes

CN Bio and the University of Melbourne collaborate to advance therapies for respiratory complications in recovered COVID-19 patients

CN Bio and the University of Melbourne collaborate to advance therapies for respiratory complications in recovered COVID-19 patients

Novel MRI contrast agent shows strong potential as safer alternative to current products

Novel MRI contrast agent shows strong potential as safer alternative to current products